CR11449A - Productos intermedios gsm - Google Patents
Productos intermedios gsmInfo
- Publication number
- CR11449A CR11449A CR11449A CR11449A CR11449A CR 11449 A CR11449 A CR 11449A CR 11449 A CR11449 A CR 11449A CR 11449 A CR11449 A CR 11449A CR 11449 A CR11449 A CR 11449A
- Authority
- CR
- Costa Rica
- Prior art keywords
- intermediate products
- gsm
- gsm intermediate
- definitions
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención se relaciona con el uso de los compuestos que tienen la Fórmula general I, en donde las definiciones o R1y R2 son proporcionadas en la especificación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98125707P | 2007-10-19 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11449A true CR11449A (es) | 2011-01-14 |
Family
ID=40092042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11449A CR11449A (es) | 2007-10-19 | 2010-05-19 | Productos intermedios gsm |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090306392A1 (es) |
EP (1) | EP2209764A1 (es) |
JP (1) | JP2011500720A (es) |
KR (1) | KR20100081350A (es) |
CN (1) | CN101903334A (es) |
AU (1) | AU2008312362A1 (es) |
BR (1) | BRPI0817789A2 (es) |
CA (1) | CA2702911A1 (es) |
CO (1) | CO6270355A2 (es) |
CR (1) | CR11449A (es) |
EA (1) | EA201070497A1 (es) |
IL (1) | IL205040A0 (es) |
MX (1) | MX2010004311A (es) |
NI (1) | NI201000067A (es) |
WO (1) | WO2009052341A1 (es) |
ZA (1) | ZA201003521B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA019710B1 (ru) * | 2007-10-19 | 2014-05-30 | Янссен Фармацевтика, Н.В. | ПРОИЗВОДНЫЕ 2-АРИЛ-4-МЕТИЛПЕНТАНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ γ-СЕКРЕТАЗЫ |
ES2378594T3 (es) * | 2007-10-19 | 2012-04-16 | Janssen Pharmaceutica, N.V. | Moduladores de piperidinilo y piperazinilo de la y-secretasa |
WO2009052350A1 (en) * | 2007-10-19 | 2009-04-23 | Janssen Pharmaceutica, N.V. | Amine linked modulators of y-secretase |
CN105646452B (zh) * | 2015-12-24 | 2018-05-01 | 北京康立生医药技术开发有限公司 | 一种蛋白激酶抑制剂的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
AU2001257022B2 (en) * | 2000-04-13 | 2005-02-03 | Mayo Foundation For Medical Education And Research | Abeta 42 lowering agents |
EP1650183A1 (en) * | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
EP1847524B1 (en) * | 2006-04-21 | 2009-10-14 | Cellzome Limited | Terphenyl derivatives for treatment of Alzheimer's disease |
PL1849762T3 (pl) * | 2006-04-21 | 2009-12-31 | Cellzome Ltd | Podstawione kwasy bifenylo-karboksylowe i ich pochodne |
-
2008
- 2008-10-17 JP JP2010530129A patent/JP2011500720A/ja not_active Withdrawn
- 2008-10-17 CN CN2008801213351A patent/CN101903334A/zh active Pending
- 2008-10-17 EA EA201070497A patent/EA201070497A1/ru unknown
- 2008-10-17 EP EP08840091A patent/EP2209764A1/en not_active Withdrawn
- 2008-10-17 CA CA2702911A patent/CA2702911A1/en not_active Abandoned
- 2008-10-17 BR BRPI0817789 patent/BRPI0817789A2/pt not_active Application Discontinuation
- 2008-10-17 US US12/253,298 patent/US20090306392A1/en not_active Abandoned
- 2008-10-17 MX MX2010004311A patent/MX2010004311A/es not_active Application Discontinuation
- 2008-10-17 WO PCT/US2008/080250 patent/WO2009052341A1/en active Application Filing
- 2008-10-17 AU AU2008312362A patent/AU2008312362A1/en not_active Abandoned
- 2008-10-17 KR KR1020107010885A patent/KR20100081350A/ko not_active Application Discontinuation
-
2010
- 2010-04-13 IL IL205040A patent/IL205040A0/en unknown
- 2010-04-16 NI NI201000067A patent/NI201000067A/es unknown
- 2010-04-30 CO CO10051575A patent/CO6270355A2/es not_active Application Discontinuation
- 2010-05-18 ZA ZA2010/03521A patent/ZA201003521B/en unknown
- 2010-05-19 CR CR11449A patent/CR11449A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA201003521B (en) | 2011-08-31 |
US20090306392A1 (en) | 2009-12-10 |
EP2209764A1 (en) | 2010-07-28 |
CA2702911A1 (en) | 2009-04-23 |
BRPI0817789A2 (pt) | 2015-03-24 |
KR20100081350A (ko) | 2010-07-14 |
JP2011500720A (ja) | 2011-01-06 |
WO2009052341A1 (en) | 2009-04-23 |
MX2010004311A (es) | 2010-05-03 |
EA201070497A1 (ru) | 2010-12-30 |
AU2008312362A1 (en) | 2009-04-23 |
AU2008312362A2 (en) | 2010-07-08 |
IL205040A0 (en) | 2010-11-30 |
CN101903334A (zh) | 2010-12-01 |
NI201000067A (es) | 2010-09-13 |
CO6270355A2 (es) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11861A (es) | Compuestos organicos | |
ECSP10010344A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
CR11454A (es) | Derivados de isoxazolo-piridina | |
SMT201400179B (it) | 1,2,5-Ossadiazoli come inibitori di indoleamina 2,3-diossigenasi | |
ECSP10010334A (es) | Derivados de quinolina y su uso como fungicidas | |
NI201200023A (es) | Derivados de 5-fluoropirimidinona | |
UY31562A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
UY31560A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
UY31563A1 (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
CO6741214A2 (es) | Composiciones pesticidas y procesos relacionados | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
NI201100108A (es) | Nuevas pirazol - 4 - n - alcoxicarboxamidas como microbicidas. | |
ECSP14013245A (es) | Nuevos derivados dihidroquinolina-2-ona | |
DOP2010000047A (es) | Compuestos de pirazol y su uso como inhibidores de raf | |
CR20150315A (es) | Biocontrol de nemátodos fitoparásitos mediante paecilomyces | |
HN2006037713A (es) | Compuestos utiles en terapia | |
DK3348624T3 (da) | Sammensætninger, der omfatter hfc-1234yf | |
UY31688A1 (es) | Plaguicidas | |
UY32553A (es) | Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos | |
DOP2006000087A (es) | Compuestos heteroaromaticos acilaminobiciclicos y sus usos | |
CR11251A (es) | Depsipeptidos ciclicos y usos de los mismos | |
UA106880C2 (uk) | Нові гербіциди | |
CY1114488T1 (el) | Διεργασιες και ενδιαμεσα για την παρασκευη ενος μακροκυκλικου αναστολεα πρωτεασης του hcv | |
SV2010003501A (es) | Fungicidas novedosos | |
UA106889C2 (uk) | Похідні n1-ацил-5-фторпіримідинону |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |